Vaidya Sane Ayurved Laboratories Limited IPO
Vaidya Sane Ayurved Laboratories Limited is an NSE SME IPO listed on the NSE SME platform, priced at ₹73 per share. The stock debuted at ₹102, delivering a listing gain of 39.7%. The IPO had a lot size of ₹1600 shares and a minimum investment of ₹1,16,800.
Vaidya Sane Ayurved Laboratories Limited IPO
- IPO Dates
- Feb 10, 2022 – Feb 15, 2022
- Price band
- ₹73 per equity share
- Minimum Investment
- ₹1,16,800
- Issue size
- 2,771,200 Eq Shares of ₹10(aggregating up to ₹20.23 Cr)
- Lot size
- 1600
- Allotment Date
- Feb 21, 2022
- Listing
- Feb 23, 2022
- Listing At
- NSE SME
IPO timeline
-
Feb 10, 2022
Open Date
Completed
-
Feb 15, 2022
Close Date
Completed
-
Feb 21, 2022
Allotment Date
Completed
-
Feb 23, 2022
Listing Date
Completed
Vaidya Sane Ayurved Laboratories Limited IPO Essentials
Vaidya Sane Ayurved Laboratories Limited IPO Details
Vaidya Sane Ayurved Laboratories Limited IPO is priced at ₹73 per share with a total issue size of 2,771,200 Eq Shares of ₹10(aggregating up to ₹20.23 Cr). The IPO has a lot size of 1600 shares and is listed on NSE SME.
- Issue price
- ₹73 per equity share
- Lot size
- 1600 shares
- Face value
- ₹10 Per Equity Share
- Issue size
- 2,771,200 Eq Shares of ₹10(aggregating up to ₹20.23 Cr)
- Listing at
- NSE SME
- List price
- 102.0
- Listing date
- Registrar
- Bigshare Services Pvt Ltd
- Lead manager
-
First Overseas Capital Limited
Vaidya Sane Ayurved Laboratories Limited IPO Analytics
Vaidya Sane Ayurved Laboratories Limited IPO category-wise subscription trends show day-wise participation across QIB, NII, and retail investors.
Vaidya Sane Ayurved Laboratories Limited IPO Subscription Status
Vaidya Sane Ayurved Laboratories Limited IPO subscription status shows demand across retail, NII, and QIB categories, helping investors understand overall participation trends.
The IPO subscription status indicates investor demand across categories.
| As on | QIB / NII | Retail | Total |
|---|---|---|---|
| Shares Offered / Reserved | 1,315,200 | 1,315,200 | 2,630,400 |
|
Day 1
10-02-22 05:30 PM
|
(0.40) x | 0.59 x | 0.49 x |
|
Day 2
11-02-22 05:30 PM
|
(0.95) x | 1.01 x | 0.98 x |
|
Day 3
14-02-22 05:30 PM
|
(1.62) x | 1.51 x | 1.56 x |
|
Day 4
15-02-22 05:30 PM
|
(2.66) x | 2.98 x | 2.82 x |
Vaidya Sane Ayurved Laboratories Limited Valuations
Earnings
- EPS (Post IPO)
- ₹1.47/-
- P/E Ratio
- 49.61
Returns
- RoNW
- 15.84%
Vaidya Sane Ayurved Laboratories Limited Financials( In Crs.)
| 30-Sep-21 | 31-Mar-21 | 31-Mar-20 | |
|---|---|---|---|
| Assets | 25.78 | 25.80 | 29.11 |
| Revenue | 31.56 | 52.27 | 75.29 |
| Profit After Tax | 1.35 | 1.54 | (0.55) |
Vaidya Sane Ayurved Laboratories Limited Company & Offer Insights
About Vaidya Sane Ayurved Laboratories Limited
Madhavbaug is a medical service institution engaged in the treatment of chronic ailments like cardiac disease, diabetes, hypertension, and obesity by combining modern technology with the traditional Ayurveda practices. It uses non-invasive, multidisciplinary, and innovative therapies for treating chronic ailments. The company mainly offers treatment for (i) Health disease reversal, (ii) Diabetes Reversal, (iii) BP Management, (iv) Obesity management, Knee pain relief.
As of November 30, 2021, the company operates 274 clinics across Maharashtra, Madhya Pradesh, Gujarat, Uttar Pradesh, Goa, Karnataka, Delhi, and Chhattisgarh. Out of these 52 are company-owned and 222 are franchise clinics. The company also operates two cardiac prevention and rehabilitation hospitals in Khopoli and Nagpur respectively.
The company offers several wellness products through their online portal Madhavbaug Wellness, and has an online app called MIB Pulse App which helps heart patients.
Vaidya Sane Ayurved Laboratories Limited Promoter(s)
Dr. Rohit Madhav Sane are the company's promoters of Vaidya Sane Ayurved Laboratories Limited.
Vaidya Sane Ayurved Laboratories Limited IPO Issue Objectives
- •
- Funding Branding and Advertising expenses
- •
- General corporate purpose
Contact Information
Frequently Asked Questions
Click any question to reveal the answer
Vaidya Sane Ayurved Laboratories Limited IPO is a Fixed Priced IPO worth ₹2,771,200 Eq Shares of ₹10(aggregating up to ₹20.23 Cr). The issue price is ₹73 per share (fixed price). The IPO opens on Feb 10, 2022 and closes on Feb 15, 2022. It will be listed on NSE SME Platform. Bigshare Services Pvt Ltd is the registrar.
The issue price of Vaidya Sane Ayurved Laboratories Limited IPO is ₹73 per share (fixed price).
The lot size of Vaidya Sane Ayurved Laboratories Limited IPO is 1600 shares.
The minimum investment for Vaidya Sane Ayurved Laboratories Limited IPO is approximately ₹1,16,800 based on the issue price .
Vaidya Sane Ayurved Laboratories Limited IPO opens on Feb 10, 2022 and closes on Feb 15, 2022.
The allotment date of Vaidya Sane Ayurved Laboratories Limited IPO is Feb 21, 2022.
Vaidya Sane Ayurved Laboratories Limited IPO is expected to be listed on Feb 23, 2022, on NSE SME Platform.
Vaidya Sane Ayurved Laboratories Limited IPO valuation snapshot: P/E 49.61, EPS ₹1.47/-, P/B N/A, RoNW 15.84%, and market cap N/A.
To apply for Vaidya Sane Ayurved Laboratories Limited IPO, open the IPO Ji app or website, select the IPO, choose your demat account, enter the quantity, and submit the application.
You can check the live subscription status of Vaidya Sane Ayurved Laboratories Limited IPO on IPO Ji or stock exchange websites. It shows real-time demand across retail, NII, and QIB categories.
Pre-apply allows investors to submit their IPO application before the bidding period starts. The order is placed automatically when the IPO opens.
If you pre-apply for Vaidya Sane Ayurved Laboratories Limited IPO, your order will be placed when the IPO bidding starts, and a UPI mandate request will be generated.
You can check Vaidya Sane Ayurved Laboratories Limited IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Vaidya Sane Ayurved Laboratories Limited IPO allotment status on IPO Ji for quick and easy access.